STEPSTONE GROUP INC. (STEP)
StepStone Group and PitchBook Announce Partnership to Deliver Deal-Level Performance & Operating Metrics to Private Market Participants
StepStone Group and PitchBook Announce Partnership to Deliver Deal-Level Performance & Operating Metrics to Private Market Participants
Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
EPAM Systems, Inc. - EPAM & Anthropic Team Up to Build the Future of Enterprise Transformation with Safe, Applied AI
Nuvation Bio Inc. - Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI®(taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer
Halozyme - Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™Technology
Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization
Veradigm Survey: Independent Practices Rely on Technology to Stay Independent
Liberty Global Tech Ventures Announces Investment in AI Security Firm, XBOW